Skip to content
Open access · CC-BY via OpenAlex

CTLA-4, PTNP-22 and FOXO-3A gene variants as genetic biomarkers for the co-occurrence of type 1 diabetes with autoimmune thyroid diseases in the Polish population

Edyta Cichocka, Anna Maj-Podsiadło, Nikola Szweda-Gandor, Janusz Gumprecht

Polskie Archiwum Medycyny Wewnętrznej · 2026

Abstract

INTRODUCTION: Genetic predisposition is a common determinant of autoimmune endocrinopathies, particularly type 1 diabetes (T1D) and autoimmune thyroid disease (AITD). Although their coexistence is frequent, the underlying genetic background is not fully understood. OBJECTIVES: We aimed to identify genetic polymorphisms predictive of an increased risk for co‑occurring T1D and AITD, and to assess their potential impact on glycemic control. PATIENTS AND METHODS: We genotyped 5 selected polymorphisms (rs3087243 and rs231775 in the CTLA4 gene; rs12730735 in the PTPN22 gene; and rs2802292 and rs9400239 in the FOXO3A gene) in 277 patients with T1D. Clinical data on thyroid status, the presence of thyroid antibodies, treatment, and metabolic control were analyzed. RESULTS: Thyroid disorders, mostly Hashimoto hypothyroidism, were diagnosed in 32.9% of the patients. As many as 75% required L‑thyroxine (mean thyroid‑stimulating hormone level, 2.15 IU/l). Among thyroid peroxidase- and thyroglobulin‑positive patients, 81.6% and 75%, respectively, had a prior diagnosis of a thyroid disorder. The GG genotype of rs3087243 (CTLA4) conferred a higher risk of hypothyroidism and other thyroid diseases. The GG variant of rs2802292 (FOXO3A) was associated with a reduced prevalence of thyroid disease in family history. Carriers of the AG genotypes in rs3087243 and rs231775 (CTLA4), as well as the GG genotype in rs2802292 (FOXO3A), showed a lower probability of achieving diabetes control, particularly with longer disease duration. However, the CT genotype of rs12730735 (PTPN22) increased the likelihood of achieving glycemic control. CONCLUSIONS: CTLA4 polymorphisms were associated with an elevated risk of a thyroid disease and poorer glycemic control; FOXO3A showed a dual role, that is, protective against familial thyroid disease but unfavorable for glycemic regulation; and the PTPN22 variant improved glycemic control. Genetic profiling may improve risk assessment and management in patients with T1D.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.20452/pamw.17189
Canonical
link ↗
Fetched
2026-10-27 MST

Cite this

APA
Cichocka, E., Maj-Podsiadło, A., Szweda-Gandor, N., &amp; Gumprecht, J. (2026). CTLA-4, PTNP-22 and FOXO-3A gene variants as genetic biomarkers for the co-occurrence of type 1 diabetes with autoimmune thyroid diseases in the Polish population. <em>Polskie Archiwum Medycyny Wewnętrznej</em>. https://doi.org/10.20452/pamw.17189
Vancouver
Cichocka E, Maj-Podsiadło A, Szweda-Gandor N, Gumprecht J. CTLA-4, PTNP-22 and FOXO-3A gene variants as genetic biomarkers for the co-occurrence of type 1 diabetes with autoimmune thyroid diseases in the Polish population. Polskie Archiwum Medycyny Wewnętrznej. 2026. doi:10.20452/pamw.17189.
BibTeX
@article{edyta2026CTLAPT, title = {CTLA-4, PTNP-22 and FOXO-3A gene variants as genetic biomarkers for the co-occurrence of type 1 diabetes with autoimmune thyroid diseases in the Polish population}, author = {Edyta Cichocka and Anna Maj-Podsiadło and Nikola Szweda-Gandor and Janusz Gumprecht}, journal = {Polskie Archiwum Medycyny Wewnętrznej}, year = {2026}, doi = {10.20452/pamw.17189}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings